HIGHLIGHTS
- who: Natalia Siminiak from the Department of Endocrinology and Metabolism, Poznau0144 University of Medical Sciences, Poznau0144, Poland have published the paper: Immunotherapy in Ovarian Cancer, in the Journal: (JOURNAL)
- what: The first clinical trial testing this approach has been completed in patients with metastatic melanoma (Rosenberg et_al 1988). Funding No outside funding or grants directly related to the research presented in this manuscript.
SUMMARY
Active immunotherapy uses the immune system to recognize and target specific cancer antigens, for example, vaccines, which stimulate the patient`s immune_response, or chimeric antigen receptor T . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.